Dermatología en Costa Rica

Thursday, June 14, 2018

Baricitinib para lupus

Baricitinib Succeeds As Treatment For Lupus In Mid-Stage Trial.

Reuters (6/13, Mathias) reports Eli Lilly & Co said baricitinib successfully treated lupus and met the main goal of a mid-stage trial. In the trial, "67 percent of patients on a 4 mg dose of baricitinib showed a resolution of arthritis or rash, common symptoms of lupus, compared with 53 percent on a placebo" after 24 weeks. The findings were presented at the Annual European Congress of Rheumatology.


Sent from my iPad
Benjamin Hidalgo-Matlock
Skin Care Physicians of Costa Rica
Clinica Victoria en San Pedro: 2224-0654
Momentum Escazu: 2101-9574
Please excuse the shortness of this message, as it has been sent from
a mobile device.

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]



<< Home